A detailed history of Petrus Trust Company, Lta transactions in Pulmonx Corp stock. As of the latest transaction made, Petrus Trust Company, Lta holds 22,612 shares of LUNG stock, worth $143,360. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,612
Previous 28,716 21.26%
Holding current value
$143,360
Previous $366,000 42.9%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$8.71 - $14.65 $53,165 - $89,423
-6,104 Reduced 21.26%
22,612 $209,000
Q4 2023

Feb 14, 2024

BUY
$7.89 - $13.14 $226,569 - $377,328
28,716 New
28,716 $366,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.